• Tidak ada hasil yang ditemukan

Validasi metoda november 2016 new

N/A
N/A
Protected

Academic year: 2017

Membagikan "Validasi metoda november 2016 new"

Copied!
186
0
0

Teks penuh

(1)

Recent development on Validation Method of

Chemical Analysis for (Phyto)Pharmaceutical Preparations

Gunawan Indrayanto

Plant Biotechnology Research Group,

Faculty of Pharmacy, Airlangga University

Surabaya 60286, Indonesi

a

[email protected]

This presentation is for Education or Training only;

this presentation is not for commercial purposes

(2)

Why chemical/Pharmaceutical analysis

is very important?

Chemical and Pharmaceutical Analysis:

Pharmaceutical/ Chemical/Food/Cosmetic Industries

Diagnostic Laboratories

Forensic Laboratories

Government Laboratories (BPOM, FDA etc)

Government Laboratories (BPOM, FDA etc)

Research

How can we have a reliable results of the

chemical analysis?

(3)

Areas

of Chemical Analysis

Quantification:

How much

of substance X, Y, Z etc is in the

sample?

Detection:

Does the sample

contain

substance X, Y, Z etc?

Does the sample

contain

substance X, Y, Z etc?

Identification:

What is the

identity

of the substance(S) in the

sample?

Separation:

How can the species of interest

be separated

from

the sample matrix for better isolation,

(4)

Valid

Methods

Calibrated

Software

?

Reference

Validation

method

compounds

Target compound

must be

stable

in the

Routine Analytical Method

IQ,

OQ, PQ

are valid

Calibrated

Instruments

Qualified

Person

must be

stable

in the

selected solvent

(5)
(6)
(7)
(8)
(9)

Reliable

and

Validated

In order to determine

the “Quality”

of any (Herbal) Drugs,

all chemicals

(API, metabolites, impurities, degradation

products, heavy metals, pesticides, preservatives, sweetener,

toxin) must be evaluated (

qualitatively and quantitatively

).

analysis’s

methods are

(10)

Validation method

for specific compound(s):

drugs, metabolites,

drugs, metabolites,

(11)
(12)

Farmakope Indonesia V

(13)
(14)
(15)
(16)

Acceptance criteria of accuracy and

precision are depended

(For compound/marker approach)

(17)

Massart’s Golden rules of Validation method

(Cited by Gonzales & Herrador,

(18)

Data Elements Required for Analytical Method Validation

Type of Analytical Procedure

Assay Impurity testing Quantitative Limit tests

(For Drugs/Cosmetic/Food analysis)

Accuracy Yes Yes Yes Yes * No * n.a No No

Precision Yes n.a Yes n.a No n.a Yes n.a No n.a

Repeatability n.a Yes n.a Yes n.a No n.a n.a n.a No

Interm. Prec. n.a Yes n.a Yes n.a No n.a n.a n.a No

Specificity Yes Yes Yes Yes Yes Yes * n.a Yes Yes

DL No No No No Yes No * n.a No No

QL No No Yes Yes No No * n.a No No

Linearity Yes Yes Yes Yes No No * n.a No No

Range Yes Yes Yes Yes * No * n.a No No

(19)

Step taken for validation Process

Analytical goal

Method selection (Published / new)

Optimization

Stability testing (SST and pre-validation)

Stability testing (SST and pre-validation)

Testing validation parameters

Validation report

Transfer of Method (R&D to QC)

(20)
(21)
(22)

For analysis using (Chromatography)

SST

must be determined

( for standard/ QC samples):

According to USP /39/40 FI V the parameters are:

Rs (usually > 1.75)

N

Tailing Factor ( nicer if ca, 1)

Requirements for doing verification of an official method

Tailing Factor ( nicer if ca, 1)

S/N ratio (>5)

Replicate Injections: see each of monographs or

% RSD (maximal)=

(23)
(24)
(25)
(26)

Definition of Markers (2008)

:

Not always = maybe “yes”

maybe “no”

(27)
(28)

Concentrations of

Selected (important) markers could

determine the activities

(29)
(30)
(31)

Pre-Validation: Stability testing

Scope:

Usage of autosampler for overnight runs with samples

in solution for hours in laboratory environment raises

concern about the stability of samples.

e.g., degradation by hydrolysis, photolysis, adhesion to

glassware, etc.,

Recommendations:

Recommendations:

Generate data to support standard and sample solution

stability under normal lab conditions for duration of

test procedure, e.g., 24 hours, 3-5 hours for TLC Profile

Acceptance Criteria

Maximal peak area difference is ± 2 %, compare to the

fresh solution

(32)
(33)
(34)
(35)
(36)

Reference standards:

originality (USP, BP, SIGMA, MERCK, etc);

(37)
(38)
(39)

Purity of the standards

-Using mass Balance Method

(40)

Mass balance for primary standard;

(It need (a) calibrated micro/analytical balances)

(41)

Smallest minimum weight

(42)

Smallest

net weight (w)

according USP: 38 /2015; 39/2016

For analytical balance d = 0.1 or 0.01mg ; micro-balance 0.001 mg,

w will be = 82 mg , 8.2 mg

,

0.82 mg

(if SD = 0 or , < 0.41 d)

Or w = 2000 SD

USP 35/FI V : Tolerance not exceed 0. 1 % of the amount weight;

(43)
(44)
(45)

Selectivity/Specificity

(46)

Specificity/Selectivity

USP, ICH, FDA: Specificity

AOAC, IUPAC : Selectivity

Specificity is

the ability to determine

the analyte unambiguously

in the presence of other components, this includes degradation

products, metabolites, matrix component etc.

products, metabolites, matrix component etc.

(47)
(48)
(49)

Selectivity evaluation for pharmaceutical preparations

:

Identity of API should be tested, and its selectivity should be

proved.

Please be careful if the identification method that described

in Pharmacopeia/ Official method is not identical with its

in Pharmacopeia/ Official method is not identical with its

assay method (e.g. Identification: IR, color reactions; assay :

HPLC

)

(50)
(51)
(52)
(53)

A B

C R & D/QC Lab. at Pharmaceutical Industry

Nice if

Densitograms (λλλλ = 260 nm) obtained from: (1) solution of standard mometasone furoate, (2) extract from excipients of laboratory-made cream, (3) extract of laboratory-made cream, (4) solution of nipagin, (5) solution of nipasol, (6) extract of commercial ointment-1, (7) extract of commercial lotion, (8) extract of commercial cream-1, (9) extract of commercial ointment-2 and (10) extract of commercial cream-2. Peak identities: (A) mometasone furoate, (B) nipagin and nipasol, (C) unknown.

Wulandari, L, Tan, KS., Indrayanto,G. (2003), J. Liq. Chromatogr. R & T, 26, 109-117

(54)

The target peak must be proved regarding its identity and purity

Peaks should be well separated

(F.Melianita, J. Witha, S.Arifin, WF.Karina, G. Indrayanto (2009).

(55)

Rs should be not less 1.75

(56)

IF Impurities, related compounds, possible Degradation products

were unavailable

Cited from: D. Widiretani, I. Luailia, G. Indrayanto,

(57)

If we have no

forced experiments to prove the selectivity.

Identity and purity check

of peaks A and B must be performed

Cited from: D. Widiretani, I. Luailia, G. Indrayanto,

(58)
(59)

Determination of Xanthorrhizol in the rhizomes of Curcuma xanthorrhiza by GC FID

Xanthorrhizol ?

(F. Melinata & G. Indrayanto (2006), Unpublished work)

Should tried

(60)

Purity Check using PDA detector (HPLC) or Densitometer (TLC-Scanner)

(61)

M.W. Dong, Modern HPLC

for Practicing Scientist, Wiley, 2006

The purity of the peak can be calculated by

(62)

Acetylsalicylic acid

200 nm

N=12804, Tf=1.20

Evaluation of the shape of acetylsalicylic acid

Evaluation of the shape of acetylsalicylic acid

chromatogram using 5 wavelengths

chromatogram using 5 wavelengths

(63)
(64)

Analysis using LC MS/MS triple Quad

(65)
(66)
(67)
(68)
(69)

(Mw: 868.04)

M. Distl et al. (2009) Potato Research 52, 39-56

(70)

The power of MRM

(71)

Why we need do the “

Why we need do the “identity test

identity test” and “

” and “

purity test

purity test” of the peaks for

” of the peaks for each

each samples for

samples for

quantitative analysis ?

quantitative analysis ?

If the peak is not the target compound,

the conclusion will be not correct.

If “impurity components” are included

in the target peak, the quantitative-results

in the target peak, the quantitative-results

will be wrong

By Using LC-MS/MS or GC-MS/MS

the target peak doesn’t need to be pure, it can

contain > 1 compounds which have same target

(72)
(73)

Linearity

The linearity of a method is its ability to provide measurement results that are directly proportional to the concentration of the analyte, or are directly proportional after mathematical transformation.

The linearity is usually documented as the ordinary least squares (OLS) curve, or simply as linear regression curve, of the measured responses (peak area or height) as a function of increasing analyte concentrations

Peak area

shall be preferred compared to peak heights for making the calibration curve

The linearity of the detector can be obtained by diluting of the analyte stock solution, whilst the linearity of the analytical method can be determined by making a series of concentration of the analyte from independent

preparations (weighing, spiking)

(74)
(75)

Analytical Methods Committee, Analyst (1988), 113: 1469-1471.

W. Horwitz, Referee (1995), December, 2.

J. van Loco; M. Elskens; C. Croux; H. Beernaert. Accred. Qual.

Assur (2002), 7: 281-285

‘Correlation coefficient (r) can not be used alone

for proving the linearity (

r close to 1 is not

a reliable indicator of linearity

)

Assur (2002), 7: 281-285

G. Indrayanto; M. Yuwono, in:J. Cazes (ed), Encyclopedia of

Chromatography (Supp.), Marcel Dekker, Inc, New York, NY

10016, 2003.

P.Araujo, J.Chromatogr.B. (2009) 877, 2224-2234

(76)

Evaluation of linearity/calibration curve

Relative process standard deviation (Vxo)- Funk’s

et al. 1992 (< 5 %); “sdv” (CATS from CAMAG) < 5

Mandel’ test (should be OK)

Residual test (should be OK)

ANOVA-linearity testing (should be OK, p < 0.01)

RSD of the Plot of response factor Vs. concentration (RSD < 2.5 – 5 %)

et al. (Xp must be less than the lowest concentration of

Xp value- Funk’s et al. (Xp must be less than the lowest concentration of the calibration curve)

% Y intercept < 2

“r” value (can not be used alone), even “r” is close to one

Fisher Ratio (according to Araujo 2009)

G value, Quality Coefficient (According to D Beer et al., 2007)

(77)
(78)
(79)

Some mathematical equations

for evaluation of linearity (Funk’s et al., 1992)

(80)
(81)

The importance of the Xp’s Value for testing the linearity

Xp values must be < X1

Lowest Highest

(82)
(83)
(84)
(85)

Proving Linearity according to Araujo (2009)

(86)

– The calibration spots should be independent of each other,

therefore spots should be applied from different, independently

weighed solutions – not by diluting from one and the same

stock solution.

Journal of Planar Chromatography 23 (2010) 3, 173–179 DOI: 10.1556/JPC.23.2010.3.1 173

0933-4173/$ 20.00 © Akadémiai Kiadó, Budapest

stock solution.

– As a consequence, calibration spots should be applied using

uniform volume of solutions, but different concentrations, to

(87)

Working range (WR) of a calibration curve can be defined as:

“the ratio of upper concentration (X

u

)

and

lower concentration (X

l

)”

In QC of Pharmaceutical Industry, WR = 1.5 – 2

Our recommendation: ± 20 % from target concentration ( with n = 4/5)

If WR > 10, It is recommended to use

“a weighting regression calibration curve”

(88)

Requirement of assay using Single point Calibration

Linear response function OK

Negligible constant systemic error (CL is not significantly different to zero, or

Negligible constant systemic error (CL is not significantly different to zero, or Intercept < 2 % from target compound )

Homogeneity of variance

(J. Ermer & P. Nethercote, Validation in PharmaceuticaAnalysis, Wiley-VCH, 2015).

Confidence range of intercept:

(89)

Detection limit (DL), Quantification limit (QL):

Impurities

Degradation products

Cleaning validation

Heavy metals

Heavy metals

Toxic metabolites

Pesticides

Waste products

Bio-analytical methods

(90)

Detection Limit & Quantitation Limit

Detection limit (DL) defined as the lowest

concentration of an analyte that can be detected under the analytical condition to be used, but cannot be measured quantitatively.

Quantitation limit (QL) is the lowest concentration that can be determined with acceptable accuracy and precision under the analytical conditions. Generally QL can be estimated as 3 times of DL.

DL and QL for instrumental (chromatographic)

analytical methods can be defined in the term of the signal-noise ratio (2-3/1 for DL and 10/1 for QL)

By constructing a linear regression of relative low concentrations of analyte, accurate value of DL can be calculated, in this case DL = Xp. We

recommend using of 5-10 relatively low

(91)
(92)

Determination of DL using method of Funk et al (DL = Xa/Xp): QL = 3DL; X2 and X1 (highest and lowest concentrations of standards) should be as low as possible!

(93)
(94)
(95)
(96)
(97)
(98)
(99)

Evaluation of Accuracy

Accuracy or trueness of an analytical method is given by the

extend by which the value obtained deviates from the true value.

Firstly accuracy can be determined by analyzing a sample with known

concentration and comparing between the measured and true value.

The second approach is by comparing test results obtained from new method with results from the existing method that known to be accurate.

The third and fourth approaches are based on the percent recovery of known analyte spiked into blank matrices or products. The last

technique is known as standard addition method.

For spiked samples into blank matrices, it is recommended to prepare sample in 5 different concentrations in the level of 80-120% of the target concentration.

For standard addition method, the spiking concentrations are 30-60 % of the label claimed

(100)
(101)
(102)

ll1.workcast.net/10311/.../MelissaHannaBrown_QbD_SepSci.pdf (2014)

(103)
(104)

Accuracy is combination of “trueness” and “precision”

(105)

PRECISION

For general rule, the standard deviation of the method should be lower

than 1/6 of the specification range or RSD value was not more than 2 %.

For method validation purposes, precision is determined by

multiple application of the complete analytical procedure on

one homogenous real sample.

According to ICH, both repeatability and intermediate precision should be

According to ICH, both repeatability and intermediate precision should be

tested

Repeatability defined as precision under the same conditions i.e. same

analyst, equipment, reagents time and column/TLC-Plate.

Intermediate precision is performed by repeatability testing on the

different combinations of analyst, equipment, reagents and time within one

laboratory. It is recommended to do 6-10 measurements on each of

repeatability study

(106)
(107)

RSD maximum for System Precision

SST replicates injections

% RSD

=

% RSD

=

Ermer. J & Nethercote, P (Eds), Method validation In Pharmaceutical Analysis, Wiely-VCH, 2015

(108)

Evaluation of the Precision

by one-way ANOVA (2 levels of precisions: Sr and SR)

If within-condition variance (repeatability) =

S

r2

, and

between-condition variance is expressed as

(S

2)

(S

B2)

Intermediate precision variance is

S

R2

= S

r2

+ S

B2

(109)
(110)

USP: Accuracy: (1) % recovery, and (2) evaluating linearity of estimated and actual concentrations (= recovery curve)

(111)

M. Yuwono & G. Indrayanto (2005), Validation method of Chromatography Methods of Analysis, Profiles of Drugs Substances, Excipients and Related Methodology,Vol. 32, Elsevier Academic Press, San Diego, New York, Boston, London, Sydney, Tokyo, Toronto, pp. 243-258

OK

Recovery CURVE

Line 2: constant systematic error

Line 3: constant and proportional systematic error

(112)

Evaluation of Accuracy:

Recovery CURVE (Funk’s

et al., 1992

):

To prove whether systematic errors did not occur, a linear regression of recovery curve of Xf (concentration of the analyte measured by the propose method) against Xc

(nominal concentration of the analyte) should be constructed

Xf = af + bf. Xc

and the confidence range (Cr) of the intercept {VB(af)} and slope {VB(bf)} from the recovery curves were calculated for p = 0.05

recovery curves were calculated for p = 0.05

(113)

Acceptance criteria

According to AOAC 2013

Trueness/Accuracy

(114)
(115)
(116)

Range:

97- 103 %

98 ± 2 %

E. Rozet, Ph. Hubert, Presentation University de Liege, Erasme, January 2012, reproduced with permission

(117)

USP Medicines Compendium, 2013)

Acceptable value

100 ± 1

https://mc.usp.org/.../10AssessValidation.pdf (discontinue March 30, 2015

For Mean± RSD

(118)

Calculation based on Cp and Cpk (“process/method capability”)

according to Kromidas

p =

p=

Cp =

(Kromidas (1999, 2011), Validerung in der Analytik, Wiley-VCH)

Cpk1 =

, Cpk2 =

Select the smaller values between Cpk 1,2

Cp / Cpk > 1.33: Very nice; 1<Cp / Cpk<1.33: Nice; Cp / Cpk <1: bad data

(119)

Probability method according USP Medicines Compendium, 2013)

(120)

According to Ermer, J & Nethercote, Eds. (2015) in his book Method Validation in Pharmaceutical Analysis:

Ti (tolerance interval = Distribution range) = ± Kf x SD

(Kf = Student t factor, or see Table:

(http://www.bessegato.com.br/UFJF/resources/tolerance_table.pdf)

Result of accuracy (R) = Mean ± Ti

(

tolerance interval

)

R can be calculated using : http://statpages.org/tolintvl.html

Acceptance criteria for accuracy & precision according to Ermer & Nethercote:

R can be calculated using : http://statpages.org/tolintvl.html

(121)
(122)

http://statpages.org/tolintvl.html

Example: Specification range : 105-95

%

Using Tolerance Table WSU for p (0.95, 0.90) k = 3.712: range 96.402-101.598% Using t table (p=95%), k = 2.571, range : 97.201- 100.79 %

(123)
(124)

Or

using new method: Accuracy Profile:

(combination of trueness, precision, (robustness) and uncertainty)

Upper Limit

G. Indrayanto In Profile of Drugs Substances,

(125)
(126)

Prediction interval

(127)

R = Mean ± ( ) x SD

Tolerance Interval (TI)

(128)

……….. : Upper specification limit (USL) %

………Lower specification Limit(LTL) %

R = Result of Accuracy: Mean ± CI/PI/TI

R (mean ± TI) must be included in the range of (USL-LTL),

if process variation is 2 %, in this case TI max should be (

λ

-2) = 3 %;

Our experiences showed that TI can be replaced by capability method

(Cp/Cpk); more works need to be performed to prove this

OK NOT OK

95 %

(129)
(130)
(131)

-x---x---x---x---x..

90.0 94.7 99.5 104.2 110.0 %

If µ1 = 99.5; 99.5 – µ2 ≤ 4.7 and 99.5 – µ2 ≥ - 4.7 (σ = 4.7); so the value of µ2 must be 94.7 < µ 2 <104.2,

(132)

Excel:

(133)
(134)
(135)
(136)

Matrix Effect

• Purpose

• To evaluate whether you have a

concentration dependent systematic

error due the matrix

• i.e. ion suppression

• How

• comparison of standard curve with

matrix matched standard curve

• Conclusion

(137)
(138)

ROBUSTNESS/RUGGEDNESS

Robustness can be defined as a measure

of its capability to remain unaffected by

small, but deliberate variations in

method parameters and provides an

indication of its reliability during normal

indication of its reliability during normal

usage.

Ruggedness of a method is the degree of

reproducibility of test results obtained by

the analysis of same samples under a

(139)

Performing an Ideal Robustness Study

The selected parameters should be studied

by using

an Experimental design

e.g

.

Plackett-Burmann Design or Fractional

Factorial Design

.

The effect(s) are calculated by using a

The effect(s) are calculated by using a

Mu

ltivariate analysis program

(e.g.

Analysis of effect)

The

most significant parameter (s)

can be

evaluated

For herbal drugs’s profile, select 3 marker

(140)

G. Indrayanto In Profile of Drugs Substances, Excipients and Related Methodology, Vol 37,

(141)
(142)

Data from: D. Widiretani, I. Luailia, G. Indrayanto, J. Planar Chromatogr.

(143)

Calculation of each effect in Robustness study

(144)
(145)
(146)

Reporting analysis results

for drug ‘assay:

: Mean/Result ± Kf x SD

,

instead of

Mean ± SD (2015, Ermer & Nethercote)

Or:

(1992; Funk et al.)

Mean/Result

± Kf x SD, or

β

<

λ

should be included in the range (upper limit – lower limit, or ±

λ

)

(147)
(148)
(149)
(150)
(151)

https://dl.dropboxusercontent.com/u/1926781/vma-1.4.3a.jar

(152)

Metabolite Profiling/Finger Printing

(153)
(154)
(155)
(156)

Market

(157)

Metabolomics : What can we do?

Modified from the Presentation of Dr.S.Park (Seoul National Univ.)

- Differentiate groups

- Find markers for the groups

- Predict the unknowns

Disease diagnosis

Plant/microorganism-metabolite profiling

Metabolomics

(158)

Principle of Metabolomics (Metabolite Profiling)

Substrate -> Product

Modified from: Schreiber, S., Nature Chemical Biology, 1, 64 (2005)

(159)
(160)
(161)
(162)

Fundamental Issue in MVS: Dimension Reduction

Bucketing

(163)
(164)

0 .0

1st step to PCA model: calculate „bucket density“

m/z

In order to enable a PCA calculation the three dimensional LC-MS dataset (RT, mass, intensity) has to be transform into a two dimensional

(165)

In

te

n

si

ty

Bucketing of „Raw Data“ = Rectangular Bucketing

Preparation for Statistics = Transformation of LC-MS Data into Table

LC-MS chromatograms of N samples

Time

(166)

Metabolomics needs Statistics

How to deal with many data sets?

In preparation for statistics, we need to convert the 3D LC-MS data into a

matrix:

(167)
(168)
(169)

LC peaks in QC sample remain

QC samples run interspersed over 150 injections of complex coffee metabolomics samples:

QC Injection No.1

QC Injection No.147

~150 Injections

QC Injection No.77

The

compact

does not need a coffee break

LC peaks in QC sample remain

constant in intensity

(170)

QC Samples cluster closely in PCA scores plot

Data acquisition and feature extraction

worked reliably

PCA scores plot

-1.0 -0.5 0.0 0.5 1.0 PC 1 -0.75

-0.50 -0.25 0.00

(171)
(172)

Application of Metabolite Profiling

for QC Herbal Drugs

(173)

WAG: Wild American Ginseng

CAG: Cultivated American Ginseng ASG: Asian Ginseng

(174)

Classification work flow

Load model for

classifcation

1

4

Load Analyses to be classified classifcation

Analyses

are processed with bucketing parameters

from model

Classification result

2

(175)
(176)
(177)
(178)
(179)
(180)
(181)
(182)

It is not only identification of

selected markers (Mars > 3), but

should be assayed, and

R must be in the specification

range, or Cp/Cpk >1 or BETI <

(183)

Final Remark for (QC Herbal) Drugs

For ensuring the quality of herbal derived drugs

a

complete quality control

was needed. The content of

selected markers and chromatographic metabolite

profile must be

both

determined and evaluated.

Authentic reference standards

were essential for

determining markers in herbal drugs, whilst for

chemical profiling

botanical reference materials

are

chemical profiling

botanical reference materials

are

needed.

The concentrations of toxic metabolites(s), heavy

metals (Hg, Pb, Cd, As), pesticides, mycotoxin

should be below

their MPL.

(184)
(185)
(186)

THANK YOU

Gambar

Table of N samples

Referensi

Dokumen terkait